Active pharmaceutical ingredient: difference between revisions
Diff·revision 16 → 17·13:54, 8 Jul 2025
Difference between revision 16 and revision 17 of Active pharmaceutical ingredient. 1 line changed; the page grew by 24 bytes.
| Revision 16 — 11:03, 20 Jun 2025 BiosimilarBoaz (talk) attribute the compounding statement to the pharmacy board that issued it 3,755 bytes ±0 | Revision 17 — 13:54, 8 Jul 2025 FiveOhThreeB (talk) correct the agency abbreviation at first use 3,779 bytes +24 | ||
|---|---|---|---|
| 46 | * [[Certificate of analysis]] | 46 | * [[Certificate of analysis]] |
| 47 | * [[ISO 9001]] | 47 | * [[ISO 9001]] |
| + | 48 | * [[Research use only]] | |
| 48 | 49 | ||
| 49 | {{DEFAULTSORT:Active pharmaceutical ingredient}} | 50 | {{DEFAULTSORT:Active pharmaceutical ingredient}} |